This article is more than 5 years old. Information may no longer be current.

CXL panel addresses new era of keratoconus management

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ANAHEIM, Calif. – Experts on a corneal crosslinking (CXL) panel spoke about the need for early screening, diagnosis and intervention of keratoconus, here at the American Academy of Optometry annual meeting. The panelists included John Gelles, OD; Shanda Ross, OD; Andrew Morgenstern, OD, FAAO; Casey Claypool, OD; and Clark Chang, OD, MS, FAAO.

Chang emphasized taking a customized, personalized approach to treatment. The experts agreed that patients must be educated on the new technology.